key: cord-0695570-zjkn83yo
authors: Kutlu, Ömer; Demirel Öğüt, Neslihan; Erbağcı, Ece; Metin, Ahmet
title: The frequency and characteristics of itching in severe COVID‐19 patients: first report
date: 2021-04-08
journal: Int J Dermatol
DOI: 10.1111/ijd.15566
sha: b815e05bf670882b3b0e4d47c170520b5cca89fe
doc_id: 695570
cord_uid: zjkn83yo

nan

ence infection risk in our patients. The lower COVID-19 rates of infection and hospitalization among women with acne were possibly related to the younger average age (acne: 33 years vs. non-acne: 35 years). Still, these data are all suggestive, as serum hormone levels were not collected in these women, and thus there is no direct evidence of the impact of androgens.

Limitations include the use of a database reflective of tertiary care facilities, low case frequency, and lack of clinical details due to the de-identified database.

While androgens likely play a role in COVID-19 outcomes, there are several other sex differences to account for, like varying immune response and the potential protective effect of estrogens/progesterone. 4 Results from ongoing trials with TMPRSS2 inhibitors and anti-androgen therapy may elucidate the impact of androgens in both sexes and have a potential role in future COVID-19 management. 5 Insight on the role of sex hormones on disease incidence and severity will contribute to better understanding of at-risk populations. before admission to the hospital. Thirty-three patients receiving medications, having itching-related systemic diseases, scabies, dermatitis, xerosis cutis, or with a prior history of itching were excluded. Sixty-one patients (45.2%) of 135 were females, and 74 (54.8%) were males. The mean age of the patients was 66.83 AE 13.09 years. There was no other cutaneous manifestation of COVID-19 in the patients. The itching was seen in 10 (7.4%) patients. The average time for itching was 1.80 AE 2.39 days. The characteristics of the patients with itching symptoms are shown in Table 1 . There was no statistically significant difference in the frequency of itching between females (6.6%) and males (8.1%) (P = 0.732). The mean age of patients with itching was 72 AE 11.68 years, while the mean age of those without itching was 66.42 AE 13.16 years. There was no statistically significant difference between the mean age of patients with and without itching (P = 0.128). Six (60%) of 10 patients had generalized itching while four had localized itching. The involvement sites of localized itching were hand, arm, shoulder, and scalp. Since all the patients had mild courses of pruritus, we took a wait-and-see approach for the management of pruritus. None of the patients required systemic antihistamine medication or any other treatment agents for pruritus.

The itching is associated with certain mediators such as histamine, leukotriene B4 (LTB4) which is a derivative of arachidonic acid, and cytokines including IL-2, IL-4, and IL-13 and especially IL-31. IL-31 is one of the main cytokines in the pruritus that is produced by CD4 + T helper cells in the setting of IL-4 secretion. In addition, IL-31 is known as the part of the IL-6 family that has both inflammatory and neuropathic properties. 5 In this study, we included COVID-19 patients who had lung involvement and found the frequency of itching as 7.4% of patients. It is well known that numerous cytokines, such as IL-2, IFNc, IL-6, and IL-10, increase in patients with COVID-19, especially in those who have severe lung involvement. 6 Although IL-31 is not among cornerstone cytokines in COVID-19, increasing of other cytokines, such as IL-2, IL-6, and IFN-c, may induce itching. Furthermore, secretion of arachidonic acids from lung cells, which results in the release of LTB4, may also contribute to the formation of itching. According to this study, although not statistically significant, itching was more common in older age and men compared to younger age and women.

These 

Androgen sensitivity gateway to COVID-19 disease severity

Cutaneous findings and systemic associations in women with polycystic ovary syndrome

California Health Creates Centralized Data Set To Accelerate COVID-19 Research

Molecular mechanisms lead to sex-specific covid-19 prognosis and targeted therapies

Sex hormones and hormone therapy during covid-19 pandemic: implications for patients with cancer

Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases

Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives

Physiology and Pathophysiology of Itch

Cytokine storm induced by SARS-CoV-2

The project described was supported by the National Center